Mach-1 Financial Group’s Zimmer Biomet ZBH Stock Holding History

Mach-1 Financial Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5	Closed	–	–	487
2022 Q3	$0	Hold	5	–	–	﹤0.01%	444
2022 Q2	$0	Hold	5	–	–	﹤0.01%	448
2022 Q1	$0	Hold	5	–	–	﹤0.01%	332
2021 Q4	$0	Buy	+5	New	+$654	﹤0.01%	310
2021 Q3	–	Sell	-5	Closed	–	–	141
2021 Q2	$0	Hold	5	–	–	﹤0.01%	211
2021 Q1	$0	Hold	5	–	–	﹤0.01%	234
2020 Q4	$0	Buy	+5	New	+$706	﹤0.01%	162

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mach-1 Financial Group's ZBH Position: Q4 2022 in Review

Mach-1 Financial Group sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 5 shares.

Mach-1 Financial Group first reported a position in ZBH in Q4 2020 and held it in 7 quarters. The position peaked at $0 in Q3 2022. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

Mach-1 Financial Group reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
Mach-1 Financial Group sold 5 Zimmer Biomet shares in Q4 2022.
Mach-1 Financial Group first reported a position in Zimmer Biomet in Q4 2020 and held it in 7 quarters.
Mach-1 Financial Group's Zimmer Biomet position peaked at $0 in Q3 2022.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Mach-1 Financial Group's 13F filing for Q4 2022, filed 2 Feb 2023.